ABIONYX Pharma SA (EPA:ABNX)
2.775
-0.025 (-0.89%)
Jun 3, 2026, 5:35 PM CET
112.48% (1Y)
| Market Cap | 98.82M +122.3% |
| Revenue (ttm) | 4.06M -10.7% |
| Net Income | -5.55M |
| EPS | -0.16 |
| Shares Out | 35.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 188,069 |
| Open | 2.775 |
| Previous Close | 2.800 |
| Day's Range | 2.725 - 2.810 |
| 52-Week Range | 1.170 - 5.290 |
| Beta | 0.58 |
| Analysts | Strong Buy |
| Price Target | 10.50 (+278.38%) |
| Earnings Date | Sep 24, 2026 |